Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine‐A
The prevalence of alcohol use disorders (AUDs) has steadily increased in the United States over the last 30 years. Alcohol acts on multiple receptor systems including the nicotinic acetylcholine receptors (nAChRs), which are known to mediate alcohol consumption and reward. We previously reported tha...
Gespeichert in:
Veröffentlicht in: | Addiction biology 2021-03, Vol.26 (2), p.e12908-n/a |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 2 |
container_start_page | e12908 |
container_title | Addiction biology |
container_volume | 26 |
creator | Touchette, Jillienne C. Moen, Janna K. Robinson, Jenna M. Lee, Anna M. |
description | The prevalence of alcohol use disorders (AUDs) has steadily increased in the United States over the last 30 years. Alcohol acts on multiple receptor systems including the nicotinic acetylcholine receptors (nAChRs), which are known to mediate alcohol consumption and reward. We previously reported that the preclinical drug sazetidine‐A, a nAChR agonist and desensitizer, reduces alcohol consumption without affecting nicotine consumption in C57BL/6J mice. Here, we found that sazetidine‐A enhances the expression of alcohol aversion without affecting the expression or acquisition of conditioned alcohol reward in C57BL/6J mice. Microinjection of sazetidine‐A into the ventral midbrain targeting the ventral tegmental area (VTA) reduced binge alcohol consumption, implicating this region in mediating the effects of sazetidine‐A. Furthermore, the sazetidine‐A‐induced reduction in alcohol consumption was mediated by non‐α4 containing nAChRs, as sazetidine‐A reduced binge alcohol consumption in both α4 knock‐out and wild‐type mice. Finally, we found that in mice pretreated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression. In summary, we find that sazetidine‐A enhances the expression of alcohol aversion, which may underlie the reduction in alcohol consumption induced by sazetidine‐A. Elucidating the identity of non‐α4 nAChRs in alcohol aversion mechanisms will provide a better understanding the complex role of nAChRs in alcohol addiction and potentially reveal novel drug targets to treat AUDs.
Sazetidine‐A enhanced the expression of alcohol aversion in the conditioned place aversion test and had no effect on the expression or acquisition of conditioned alcohol reward in the conditioned place preference test in mice. Sazetidine‐A did not require the alpha4 nAChR subunit to reduce binge alcohol consumption, implicating non‐alpha4 containing nAChRs. In mice pre‐treated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression. |
doi_str_mv | 10.1111/adb.12908 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7584768</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2489900047</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4438-f9b70da3172c64e89757dfee0124f29f57140cd029fb4f8b37ef6647b3bd9c2b3</originalsourceid><addsrcrecordid>eNp1kU1uFDEQhS0EIiGw4ALIEhtYdOK_9s8GaUhCQIrEBlYsLNtdnXHU0x7s7kSTVY7AGTkJnkyIAIlaVJVUn55e6SH0kpJDWuvIdf6QMkP0I7RPuTQNlYQ83u5t20hG2z30rJRLQihTLX-K9jjjzLRS7aNvp-PSjQFWME449dgNIS3TgN0V5BLTiP0GT0vAYwxpirVjF2DaDKFCcQScIcB6Shl3eb7Axd3AFLt6-Hn7Y_EcPendUODF_TxAXz-cfjn-2Jx_Pvt0vDhvghBcN73xinSOU8WCFKCNalXXA1S3omembxUVJHSkrl702nMFvZRCee47E5jnB-jdTnc9-xV0ob6S3WDXOa5c3tjkov37MsalvUhXVrVaKKmrwJt7gZy-z1Amu4olwDC4EdJcLONGaC2JVBV9_Q96meY81vcsE9oYQojYUm93VMiplAz9gxlK7DYyWyOzd5FV9tWf7h_I3xlV4GgHXMcBNv9XsouT9zvJX3mQom0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2489900047</pqid></control><display><type>article</type><title>Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine‐A</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Touchette, Jillienne C. ; Moen, Janna K. ; Robinson, Jenna M. ; Lee, Anna M.</creator><creatorcontrib>Touchette, Jillienne C. ; Moen, Janna K. ; Robinson, Jenna M. ; Lee, Anna M.</creatorcontrib><description>The prevalence of alcohol use disorders (AUDs) has steadily increased in the United States over the last 30 years. Alcohol acts on multiple receptor systems including the nicotinic acetylcholine receptors (nAChRs), which are known to mediate alcohol consumption and reward. We previously reported that the preclinical drug sazetidine‐A, a nAChR agonist and desensitizer, reduces alcohol consumption without affecting nicotine consumption in C57BL/6J mice. Here, we found that sazetidine‐A enhances the expression of alcohol aversion without affecting the expression or acquisition of conditioned alcohol reward in C57BL/6J mice. Microinjection of sazetidine‐A into the ventral midbrain targeting the ventral tegmental area (VTA) reduced binge alcohol consumption, implicating this region in mediating the effects of sazetidine‐A. Furthermore, the sazetidine‐A‐induced reduction in alcohol consumption was mediated by non‐α4 containing nAChRs, as sazetidine‐A reduced binge alcohol consumption in both α4 knock‐out and wild‐type mice. Finally, we found that in mice pretreated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression. In summary, we find that sazetidine‐A enhances the expression of alcohol aversion, which may underlie the reduction in alcohol consumption induced by sazetidine‐A. Elucidating the identity of non‐α4 nAChRs in alcohol aversion mechanisms will provide a better understanding the complex role of nAChRs in alcohol addiction and potentially reveal novel drug targets to treat AUDs.
Sazetidine‐A enhanced the expression of alcohol aversion in the conditioned place aversion test and had no effect on the expression or acquisition of conditioned alcohol reward in the conditioned place preference test in mice. Sazetidine‐A did not require the alpha4 nAChR subunit to reduce binge alcohol consumption, implicating non‐alpha4 containing nAChRs. In mice pre‐treated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression.</description><identifier>ISSN: 1355-6215</identifier><identifier>EISSN: 1369-1600</identifier><identifier>DOI: 10.1111/adb.12908</identifier><identifier>PMID: 32329567</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>Acetylcholine receptors (nicotinic) ; Addictions ; Alcohol ; Alcohol Deterrents - pharmacology ; Alcoholism - drug therapy ; Animals ; Aversion ; Azetidines - pharmacology ; Binge Drinking - drug therapy ; Drug addiction ; Female ; Fos ; Male ; Mesencephalon ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Microinjection ; Nicotine ; nicotinic acetylcholine receptor ; Nicotinic Agonists - pharmacology ; Proto-Oncogene Proteins c-fos - drug effects ; Pyridines - pharmacology ; Receptors, Nicotinic ; Reinforcement ; Reward ; Therapeutic targets ; Transcription ; Ventral Tegmental Area - drug effects ; Ventral tegmentum ; VTA</subject><ispartof>Addiction biology, 2021-03, Vol.26 (2), p.e12908-n/a</ispartof><rights>2020 Society for the Study of Addiction</rights><rights>2020 Society for the Study of Addiction.</rights><rights>2021 Society for the Study of Addiction</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4438-f9b70da3172c64e89757dfee0124f29f57140cd029fb4f8b37ef6647b3bd9c2b3</citedby><cites>FETCH-LOGICAL-c4438-f9b70da3172c64e89757dfee0124f29f57140cd029fb4f8b37ef6647b3bd9c2b3</cites><orcidid>0000-0003-4551-0082 ; 0000-0001-6167-5472</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fadb.12908$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fadb.12908$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32329567$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Touchette, Jillienne C.</creatorcontrib><creatorcontrib>Moen, Janna K.</creatorcontrib><creatorcontrib>Robinson, Jenna M.</creatorcontrib><creatorcontrib>Lee, Anna M.</creatorcontrib><title>Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine‐A</title><title>Addiction biology</title><addtitle>Addict Biol</addtitle><description>The prevalence of alcohol use disorders (AUDs) has steadily increased in the United States over the last 30 years. Alcohol acts on multiple receptor systems including the nicotinic acetylcholine receptors (nAChRs), which are known to mediate alcohol consumption and reward. We previously reported that the preclinical drug sazetidine‐A, a nAChR agonist and desensitizer, reduces alcohol consumption without affecting nicotine consumption in C57BL/6J mice. Here, we found that sazetidine‐A enhances the expression of alcohol aversion without affecting the expression or acquisition of conditioned alcohol reward in C57BL/6J mice. Microinjection of sazetidine‐A into the ventral midbrain targeting the ventral tegmental area (VTA) reduced binge alcohol consumption, implicating this region in mediating the effects of sazetidine‐A. Furthermore, the sazetidine‐A‐induced reduction in alcohol consumption was mediated by non‐α4 containing nAChRs, as sazetidine‐A reduced binge alcohol consumption in both α4 knock‐out and wild‐type mice. Finally, we found that in mice pretreated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression. In summary, we find that sazetidine‐A enhances the expression of alcohol aversion, which may underlie the reduction in alcohol consumption induced by sazetidine‐A. Elucidating the identity of non‐α4 nAChRs in alcohol aversion mechanisms will provide a better understanding the complex role of nAChRs in alcohol addiction and potentially reveal novel drug targets to treat AUDs.
Sazetidine‐A enhanced the expression of alcohol aversion in the conditioned place aversion test and had no effect on the expression or acquisition of conditioned alcohol reward in the conditioned place preference test in mice. Sazetidine‐A did not require the alpha4 nAChR subunit to reduce binge alcohol consumption, implicating non‐alpha4 containing nAChRs. In mice pre‐treated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression.</description><subject>Acetylcholine receptors (nicotinic)</subject><subject>Addictions</subject><subject>Alcohol</subject><subject>Alcohol Deterrents - pharmacology</subject><subject>Alcoholism - drug therapy</subject><subject>Animals</subject><subject>Aversion</subject><subject>Azetidines - pharmacology</subject><subject>Binge Drinking - drug therapy</subject><subject>Drug addiction</subject><subject>Female</subject><subject>Fos</subject><subject>Male</subject><subject>Mesencephalon</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Microinjection</subject><subject>Nicotine</subject><subject>nicotinic acetylcholine receptor</subject><subject>Nicotinic Agonists - pharmacology</subject><subject>Proto-Oncogene Proteins c-fos - drug effects</subject><subject>Pyridines - pharmacology</subject><subject>Receptors, Nicotinic</subject><subject>Reinforcement</subject><subject>Reward</subject><subject>Therapeutic targets</subject><subject>Transcription</subject><subject>Ventral Tegmental Area - drug effects</subject><subject>Ventral tegmentum</subject><subject>VTA</subject><issn>1355-6215</issn><issn>1369-1600</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU1uFDEQhS0EIiGw4ALIEhtYdOK_9s8GaUhCQIrEBlYsLNtdnXHU0x7s7kSTVY7AGTkJnkyIAIlaVJVUn55e6SH0kpJDWuvIdf6QMkP0I7RPuTQNlYQ83u5t20hG2z30rJRLQihTLX-K9jjjzLRS7aNvp-PSjQFWME449dgNIS3TgN0V5BLTiP0GT0vAYwxpirVjF2DaDKFCcQScIcB6Shl3eb7Axd3AFLt6-Hn7Y_EcPendUODF_TxAXz-cfjn-2Jx_Pvt0vDhvghBcN73xinSOU8WCFKCNalXXA1S3omembxUVJHSkrl702nMFvZRCee47E5jnB-jdTnc9-xV0ob6S3WDXOa5c3tjkov37MsalvUhXVrVaKKmrwJt7gZy-z1Amu4olwDC4EdJcLONGaC2JVBV9_Q96meY81vcsE9oYQojYUm93VMiplAz9gxlK7DYyWyOzd5FV9tWf7h_I3xlV4GgHXMcBNv9XsouT9zvJX3mQom0</recordid><startdate>202103</startdate><enddate>202103</enddate><creator>Touchette, Jillienne C.</creator><creator>Moen, Janna K.</creator><creator>Robinson, Jenna M.</creator><creator>Lee, Anna M.</creator><general>John Wiley & Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7T5</scope><scope>7TM</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4551-0082</orcidid><orcidid>https://orcid.org/0000-0001-6167-5472</orcidid></search><sort><creationdate>202103</creationdate><title>Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine‐A</title><author>Touchette, Jillienne C. ; Moen, Janna K. ; Robinson, Jenna M. ; Lee, Anna M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4438-f9b70da3172c64e89757dfee0124f29f57140cd029fb4f8b37ef6647b3bd9c2b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acetylcholine receptors (nicotinic)</topic><topic>Addictions</topic><topic>Alcohol</topic><topic>Alcohol Deterrents - pharmacology</topic><topic>Alcoholism - drug therapy</topic><topic>Animals</topic><topic>Aversion</topic><topic>Azetidines - pharmacology</topic><topic>Binge Drinking - drug therapy</topic><topic>Drug addiction</topic><topic>Female</topic><topic>Fos</topic><topic>Male</topic><topic>Mesencephalon</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Microinjection</topic><topic>Nicotine</topic><topic>nicotinic acetylcholine receptor</topic><topic>Nicotinic Agonists - pharmacology</topic><topic>Proto-Oncogene Proteins c-fos - drug effects</topic><topic>Pyridines - pharmacology</topic><topic>Receptors, Nicotinic</topic><topic>Reinforcement</topic><topic>Reward</topic><topic>Therapeutic targets</topic><topic>Transcription</topic><topic>Ventral Tegmental Area - drug effects</topic><topic>Ventral tegmentum</topic><topic>VTA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Touchette, Jillienne C.</creatorcontrib><creatorcontrib>Moen, Janna K.</creatorcontrib><creatorcontrib>Robinson, Jenna M.</creatorcontrib><creatorcontrib>Lee, Anna M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Addiction biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Touchette, Jillienne C.</au><au>Moen, Janna K.</au><au>Robinson, Jenna M.</au><au>Lee, Anna M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine‐A</atitle><jtitle>Addiction biology</jtitle><addtitle>Addict Biol</addtitle><date>2021-03</date><risdate>2021</risdate><volume>26</volume><issue>2</issue><spage>e12908</spage><epage>n/a</epage><pages>e12908-n/a</pages><issn>1355-6215</issn><eissn>1369-1600</eissn><abstract>The prevalence of alcohol use disorders (AUDs) has steadily increased in the United States over the last 30 years. Alcohol acts on multiple receptor systems including the nicotinic acetylcholine receptors (nAChRs), which are known to mediate alcohol consumption and reward. We previously reported that the preclinical drug sazetidine‐A, a nAChR agonist and desensitizer, reduces alcohol consumption without affecting nicotine consumption in C57BL/6J mice. Here, we found that sazetidine‐A enhances the expression of alcohol aversion without affecting the expression or acquisition of conditioned alcohol reward in C57BL/6J mice. Microinjection of sazetidine‐A into the ventral midbrain targeting the ventral tegmental area (VTA) reduced binge alcohol consumption, implicating this region in mediating the effects of sazetidine‐A. Furthermore, the sazetidine‐A‐induced reduction in alcohol consumption was mediated by non‐α4 containing nAChRs, as sazetidine‐A reduced binge alcohol consumption in both α4 knock‐out and wild‐type mice. Finally, we found that in mice pretreated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression. In summary, we find that sazetidine‐A enhances the expression of alcohol aversion, which may underlie the reduction in alcohol consumption induced by sazetidine‐A. Elucidating the identity of non‐α4 nAChRs in alcohol aversion mechanisms will provide a better understanding the complex role of nAChRs in alcohol addiction and potentially reveal novel drug targets to treat AUDs.
Sazetidine‐A enhanced the expression of alcohol aversion in the conditioned place aversion test and had no effect on the expression or acquisition of conditioned alcohol reward in the conditioned place preference test in mice. Sazetidine‐A did not require the alpha4 nAChR subunit to reduce binge alcohol consumption, implicating non‐alpha4 containing nAChRs. In mice pre‐treated with sazetidine‐A, alcohol induced Fos transcript in Th‐, but not Gad2‐expressing neurons in the VTA as measured by increased Fos transcript expression.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>32329567</pmid><doi>10.1111/adb.12908</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-4551-0082</orcidid><orcidid>https://orcid.org/0000-0001-6167-5472</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1355-6215 |
ispartof | Addiction biology, 2021-03, Vol.26 (2), p.e12908-n/a |
issn | 1355-6215 1369-1600 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7584768 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Acetylcholine receptors (nicotinic) Addictions Alcohol Alcohol Deterrents - pharmacology Alcoholism - drug therapy Animals Aversion Azetidines - pharmacology Binge Drinking - drug therapy Drug addiction Female Fos Male Mesencephalon Mice Mice, Inbred C57BL Mice, Knockout Microinjection Nicotine nicotinic acetylcholine receptor Nicotinic Agonists - pharmacology Proto-Oncogene Proteins c-fos - drug effects Pyridines - pharmacology Receptors, Nicotinic Reinforcement Reward Therapeutic targets Transcription Ventral Tegmental Area - drug effects Ventral tegmentum VTA |
title | Enhancement of alcohol aversion by the nicotinic acetylcholine receptor drug sazetidine‐A |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T14%3A09%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhancement%20of%20alcohol%20aversion%20by%20the%20nicotinic%20acetylcholine%20receptor%20drug%20sazetidine%E2%80%90A&rft.jtitle=Addiction%20biology&rft.au=Touchette,%20Jillienne%20C.&rft.date=2021-03&rft.volume=26&rft.issue=2&rft.spage=e12908&rft.epage=n/a&rft.pages=e12908-n/a&rft.issn=1355-6215&rft.eissn=1369-1600&rft_id=info:doi/10.1111/adb.12908&rft_dat=%3Cproquest_pubme%3E2489900047%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2489900047&rft_id=info:pmid/32329567&rfr_iscdi=true |